$272.58
0.64% day before yesterday
NYSE, Dec 06, 10:13 pm CET
ISIN
US0311621009
Symbol
AMGN
Sector
Industry

Amgen Target price 2024 - Analyst rating & recommendation

Amgen Classifications & Recommendation:

Buy
44%
Hold
50%
Sell
6%

Amgen Price Target

Target Price $329.57
Price $272.58
Potential 20.91%
Number of Estimates 23
23 Analysts have issued a price target Amgen 2025 . The average Amgen target price is $329.57. This is 20.91% higher than the current stock price. The highest price target is $405.00 48.58% , the lowest is $195.00 28.46% .
A rating was issued by 34 analysts: 15 Analysts recommend Amgen to buy, 17 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Amgen stock has an average upside potential 2025 of 20.91% . Most analysts recommend the Amgen stock at Hold.

Sales and Margin forecast 2024, 2025 to 2028


Dec '23 2024
Estimates
Revenue Billion $ 28.01 33.18
7.35% 18.44%
EBITDA Margin 44.11% 57.93%
8.62% 31.32%
Net Margin 23.97% 14.75%
3.92% 38.46%

27 Analysts have issued a sales forecast Amgen 2024 . The average Amgen sales estimate is $33.2b . This is 2.63% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $33.5b 3.75% , the lowest is $32.9b 1.78% .

This results in the following potential growth metrics:

Revenue Estimates

2023 $28.0b 7.35%
2024 $33.2b 18.44%
2025 $34.3b 3.51%
2026 $34.9b 1.52%
2027 $35.5b 1.86%
2028 $36.3b 2.20%

7 Analysts have issued an Amgen EBITDA forecast 2024. The average Amgen EBITDA estimate is $19.2b . This is 59.02% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $20.5b 69.34% , the lowest is $18.3b 51.47% .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $12.4b 1.91%
2024 $19.2b 55.54%
2025 $17.9b 6.98%
2026 $17.8b 0.27%
2027 $19.3b 8.26%
2028 $19.7b 2.06%

EBITDA Margin

2023 44.11% 8.62%
2024 57.93% 31.32%
2025 52.06% 10.13%
2026 51.14% 1.77%
2027 54.36% 6.30%
2028 54.28% 0.15%

10 Amgen Analysts have issued a net profit forecast 2024. The average Amgen net profit estimate is $4.9b . This is 16.56% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $6.3b 49.30% , the lowest is $4.1b 2.89% .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $6.7b 3.14%
2024 $4.9b 27.11%
2025 $5.6b 14.29%
2026 $6.5b 16.05%
2027 $9.1b 39.99%
2028 $10.0b 9.74%

Net Margin

2023 23.97% 3.92%
2024 14.75% 38.46%
2025 16.29% 10.44%
2026 18.62% 14.30%
2027 25.59% 37.43%
2028 27.48% 7.39%

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028


Dec '23 2024
Estimates
Earnings Per Share $ 12.49 9.10
3.14% 27.14%
P/E 29.94
EV/Sales 5.97

10 Analysts have issued a Amgen forecast for earnings per share. The average Amgen <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $9.10 . This is 16.52% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $11.66 49.30% , the lowest is $7.58 2.94% .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $12.49 3.14%
2024 $9.10 27.14%
2025 $10.41 14.40%
2026 $12.07 15.95%
2027 $16.90 40.02%
2028 $18.55 9.76%

P/E ratio

Current 34.90 80.18%
2024 29.94 14.21%
2025 26.20 12.49%
2026 22.57 13.85%
2027 16.13 28.53%
2028 14.69 8.93%

Based on analysts' sales estimates for 2024, the Amgen stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 5.97 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 4.42 .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 6.12 4.97%
2024 5.97 2.52%
2025 5.76 3.39%
2026 5.68 1.49%
2027 5.57 1.83%
2028 5.45 2.15%

P/S ratio

Current 4.53 17.21%
2024 4.42 2.57%
2025 4.27 3.39%
2026 4.20 1.50%
2027 4.13 1.82%
2028 4.04 2.15%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today